Last reviewed · How we verify
Ketorolac 30 mg
At a glance
| Generic name | Ketorolac 30 mg |
|---|---|
| Sponsor | Cairo University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Rectal Indomethacin vs Intravenous Ketorolac (PHASE4)
- Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy (PHASE2, PHASE3)
- Opioid-Free vs Opioid-Based Anesthesia in Bariatric Surgery (NA)
- Dosing of Ketorolac Impacts Post-cesarean paiN manaGemenet (KING) (PHASE4)
- Optimizing Pain Treatment in Children On Mechanical Ventilation (PHASE3)
- Femoral Rami Obturator Nerve Trunk (FRONT) Block in Intramedullary Nail Surgery . (NA)
- Ketorolac Intravenous Regional Analgesia in Lower Limb Surgeries (NA)
- Opioid-Free Pain Protocol After Shoulder Arthroplasty (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ketorolac 30 mg CI brief — competitive landscape report
- Ketorolac 30 mg updates RSS · CI watch RSS
- Cairo University portfolio CI